Address by the Prime Minister at the Inaugural Session of the World Innovation Summit, 2021

India Narendra Modi · Prime Minister of India

18 November 2021 · World Innovation Summit 2021 (Inaugural Session)

Context
Modi addressed the inaugural session of the World Innovation Summit 2021 organized by the Indian Pharmaceutical Alliance, focusing on India's pharma sector and innovation.
Main themes
Pharmaceutical innovation, COVID-19 pandemic response, India as global pharmacy, vaccine production and export, healthcare sector growth, research and development policy, Make in India initiative, traditional medicine, raw material self-reliance, foreign direct investment in pharma, industry-academia collaboration
Duration
~7 min
25th percentile
Words
871
25th percentile
Sentences
64
42nd percentile
Readability
49
60th percentile
Grade
9.8
19th percentile
Syntax
2.49
3rd percentile
Vocabulary
2.28
68th percentile

Translated from Assamese

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Economic 50%50%
  • Social 22%22%
  • Ceremonial 22%22%
  • Institutional 6%6%
  • Geopolitical 0%0%
  • Technological 0%0%
  • Environmental 0%0%
  • Not in focus 0%

64 sentences in 28 paragraphs

My

Cabinet

Esteemed Shri Mansukh Bhai, President of the Indian Pharmaceutical Alliance, Shri Sameer Mehta, President of Cadila Healthcare Limited, Shri Pankaj Patel, distinguished participants,

Namaste!

To begin with, I congratulate the Indian Pharmaceutical Association for organizing this Global Innovation Summit.

The COVID-19 pandemic has highlighted the importance of the healthcare sector. Whether it is lifestyle or medicines, medical technology or vaccines, every aspect of healthcare has attracted global attention in the last two years. In this context, the Indian pharmaceutical industry has also faced challenges.

Due to the global trust earned by the Indian healthcare sector, India has recently been referred to as the "pharmacy of the world." With nearly 3 million people employed and creating a trade surplus of about 13 billion dollars, the Indian pharma industry has become a key driver of our economic growth.

The combination of affordable prices and high standards and volumes has generated significant interest in the Indian pharma sector worldwide. Since 2014, the Indian healthcare sector has attracted 12 billion dollars in foreign direct investment. And, there is still much potential.

Friends,

Our definition of welfare is not limited by physical boundaries. We believe in the welfare of all humanity.

Sarve bhavantu sukhinah: Sarve santu niramayah.

And, we have demonstrated this mindset to the entire world during the COVID-19 global pandemic. In the early stages of the pandemic, we exported life-saving medicines and medical supplies to 150 countries. This year, we have exported 65 million doses of COVID vaccines to nearly 100 countries. In the coming months, as we increase our vaccine production capacity, we will do much more.

Friends,

The importance of innovation in all aspects of life has been reinforced during the COVID-19 era. This disruption has compelled us to rethink our lifestyles, the way we think and work. The context of the Indian pharma sector has indeed become exciting in terms of speed, scale, and the impetus for innovation. For example, as a result of this impetus for innovation, India has emerged as a major producer and exporter of PPE. And, due to the same innovative mindset, India is at the forefront of the development, production, distribution, and export of COVID-19 vaccines.

Friends,

The proactive steps taken by the Government of India to foster the growth of the pharma sector reflect the same innovative mindset. Last month, the government released a draft document outlining the "Policy to Promote Research and Development and Innovation in India's Pharma-Medtech Sector." This policy reflects India's commitment to encouraging research and development in pharmaceuticals and medical devices.

Our vision is to create an environment for innovation that will establish India as a hub for drug discovery and innovative medical devices. Our policy interventions have been based on extensive consultations with all stakeholders. We are sensitive to the demands of the industry regarding regulatory frameworks and are actively working in this direction. The industry has gained significant momentum through the production-linked incentive scheme worth 30,000 crore rupees for pharmaceuticals and medical devices.

Friends,

Support from the industry, the academic world, and especially our talented youth is crucial. Therefore, we are fostering collaboration between education and industry. India has a large base of scientists and technologists who have the potential to take the industry to greater heights. This strength needs to be transformed into "Discover and Make in India."

Friends,

I also wish to shed light on two areas that I urge you to explore carefully. The first relates to the need for raw materials. While fighting COVID-19, we saw that this is an issue that requires more attention. Today, as India takes on the responsibility of self-reliance for its 1.3 billion people, we must certainly think about increasing domestic production of key ingredients for vaccines and medicines. This is a frontier that India must cross.

I am confident that investors and innovators will be eager to work together to overcome this challenge. The second area relates to India's traditional medicines. There is now significant and growing demand for these products in the international market. This has been evidenced by the sharp increase in exports of these products in recent years. In just 2020-21, India exported herbal medicines worth over 1.5 billion dollars. The World Health Organization is also working to establish a global center for traditional medicine in India. Can we think of more ways to popularize our traditional medicines in line with global needs, scientific standards, and best manufacturing practices?

Friends,

I invite all of you to embrace the spirit of "Innovate in India, Make in India" and prepare for the world. Unleash your true potential and serve the world.

We have the necessary talent, resources, and environment for innovation and entrepreneurship. The pharma sector's swift actions, our impetus for innovation, and our successes have caught the world's attention. This is the best time to move forward and ascend to new heights. I assure global and domestic industry leaders and partners that India is committed to creating an environment conducive to innovation. I hope this summit serves as a flagbearer for strengthening the position of the Indian pharmaceutical industry in research, development, and innovation.

Once again, I congratulate the organizers and wish for fruitful discussions during these two days.

Thank you.

Thank you very much.